NCM · Financial Statements

Ovid Therapeutics Inc. (OVID) Financial Statements

$2.34 NCM: OVID Market Cap $436.74M

Ovid Therapeutics Inc. most recently reported annual revenue of $7.0M, net profit of $-17.0M, revenue has compounded at -11.6% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$208.0M$2.0M$0$1.0M$7.0M
Operating Profit$124.0M$-56.0M$-59.0M$-62.0M$-42.0M
Net Profit$123.0M$-54.0M$-52.0M$-26.0M$-17.0M
EPS$1.76$-0.77$-0.74$-0.37$-0.24
Op Margin59.6%-3696.4%-15122.7%-10933.8%-585.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$195.0M$155.0M$144.0M$92.0M$151.0M
Total Liabilities$15.0M$23.0M$56.0M$24.0M$20.0M
Cash$188.0M$45.0M$27.0M$26.0M$13.0M
Borrowings$0$17.0M$16.0M$15.0M$13.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$119.0M$-55.0M$-46.0M$-56.0M$-38.0M
Investing Cash Flow$-2.0M$-89.0M$-3.0M$55.0M$-50.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$118.0M$-143.0M$-18.0M$-1.0M$-13.0M
Free Cash Flow$118.0M$-57.0M$-46.0M$-56.0M$-38.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.14
EV / EBITDA-12.29
FCF Yield-12.54%
Quick Ratio12.39
Interest Coverage0.00
Return 1Y242.86%
Return 3Y-32.96%
Return 5Y-33.33%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
OVID Overview OVID Dividend Run Stock Screener